Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 714

1.

Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events.

Koh KK, Sakuma I, Shimada K, Hayashi T, Quon MJ.

Korean Circ J. 2017 Jul;47(4):432-439. doi: 10.4070/kcj.2016.0406. Epub 2017 Jul 26. Review.

2.

Prediction of new onset of end stage renal disease in Chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.

Wan EYF, Fong DYT, Fung CSC, Yu EYT, Chin WY, Chan AKC, Lam CLK.

BMC Nephrol. 2017 Aug 1;18(1):257. doi: 10.1186/s12882-017-0671-x.

3.

Leptin is an independent marker of metabolic syndrome in elderly adults with type 2 diabetes.

Tseng PW, Wu DA, Hou JS, Hsu BG.

Ci Ji Yi Xue Za Zhi. 2017 Apr-Jun;29(2):109-114. doi: 10.4103/tcmj.tcmj_31_17.

4.

Correlation between Glycated Hemoglobin and Triglyceride Level in Type 2 Diabetes Mellitus.

Naqvi S, Naveed S, Ali Z, Ahmad SM, Asadullah Khan R, Raj H, Shariff S, Rupareliya C, Zahra F, Khan S.

Cureus. 2017 Jun 13;9(6):e1347. doi: 10.7759/cureus.1347.

5.
6.

A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome.

Tabeshpour J, Imenshahidi M, Hosseinzadeh H.

Iran J Basic Med Sci. 2017 May;20(5):557-568. doi: 10.22038/IJBMS.2017.8682. Review.

7.

Lower Extremity Peripheral Arterial Disease Is an Independent Predictor of Coronary Heart Disease and Stroke Risks in Patients with Type 2 Diabetes Mellitus in China.

Pang XH, Han J, Ye WL, Sun X, Ding Y, Huang WJ, Zhao YM, Lou HY, Shan LZ, Kang YX, Song XX, Zhang SZ, Gu W, Shan PF.

Int J Endocrinol. 2017;2017:9620513. doi: 10.1155/2017/9620513. Epub 2017 May 8.

8.

Red cell distribution width as a significant indicator of medication and prognosis in type 2 diabetic patients.

Xiong XF, Yang Y, Chen X, Zhu X, Hu C, Han Y, Zhao L, Liu F, Sun L.

Sci Rep. 2017 Jun 2;7(1):2709. doi: 10.1038/s41598-017-02904-9.

9.
10.

Midlife and Late-Life Vascular Risk Factors and White Matter Microstructural Integrity: The Atherosclerosis Risk in Communities Neurocognitive Study.

Power MC, Tingle JV, Reid RI, Huang J, Sharrett AR, Coresh J, Griswold M, Kantarci K, Jack CR Jr, Knopman D, Gottesman RF, Mosley TH.

J Am Heart Assoc. 2017 May 18;6(5). pii: e005608. doi: 10.1161/JAHA.117.005608.

11.

Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus.

Budoff MJ, Wilding JPH.

Int J Clin Pract. 2017 May;71(5). doi: 10.1111/ijcp.12948. Review.

12.
13.
14.
15.

Alterations of Urinary Microbiota in Type 2 Diabetes Mellitus with Hypertension and/or Hyperlipidemia.

Liu F, Ling Z, Xiao Y, Yang Q, Wang B, Zheng L, Jiang P, Li L, Wang W.

Front Physiol. 2017 Mar 3;8:126. doi: 10.3389/fphys.2017.00126. eCollection 2017.

16.

Protocol for Evaluating the Cardio-Ankle Vascular Index to Predict Cardiovascular Events in Japan: A Prospective Multicenter Cohort Study.

Miyoshi T, Ito H, Horinaka S, Shirai K, Higaki J, Orimio H.

Pulse (Basel). 2017 Jan;4(Suppl 1):11-16. doi: 10.1159/000448464. Epub 2016 Dec 23. Review.

17.

Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood.

Dabelea D, Stafford JM, Mayer-Davis EJ, D'Agostino R Jr, Dolan L, Imperatore G, Linder B, Lawrence JM, Marcovina SM, Mottl AK, Black MH, Pop-Busui R, Saydah S, Hamman RF, Pihoker C; SEARCH for Diabetes in Youth Research Group.

JAMA. 2017 Feb 28;317(8):825-835. doi: 10.1001/jama.2017.0686.

18.
19.

Metabolic syndrome's risk factors and its association with nutritional status in schoolchildren.

Teixeira FC, Pereira FE, Pereira AF, Ribeiro BG.

Prev Med Rep. 2017 Feb 8;6:27-32. doi: 10.1016/j.pmedr.2017.02.002. eCollection 2017 Jun.

20.

A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation.

Ott C, Jumar A, Striepe K, Friedrich S, Karg MV, Bramlage P, Schmieder RE.

Cardiovasc Diabetol. 2017 Feb 23;16(1):26. doi: 10.1186/s12933-017-0510-1.

Supplemental Content

Loading ...
Support Center